Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies
Neural cell transplantation and gene therapy have attracted considerable interest as promising therapeutic alternatives for patients with Parkinson's disease (PD). Preclinical and open-label studies have suggested that grafted fetal neural tissue or viral vector gene transfer can achieve consid...
Saved in:
Main Authors: | Zinovia Kefalopoulou, Iciar Aviles-Olmos, Thomas Foltynie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.4061/2011/804041 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding and Prevention of “Therapy-” Induced Dyskinesias
by: Iciar Aviles-Olmos, et al.
Published: (2012-01-01) -
Clinical trials to gene therapy development and production in Brazil: a review
by: Jonas Alex Morales Saute, et al.
Published: (2025-03-01) -
The Clinical Trials of Mesenchymal Stromal Cells Therapy
by: Mohammad Reza Kouchakian, et al.
Published: (2021-01-01) -
A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia
by: Punam P. Parikh, et al.
Published: (2017-01-01) -
Novel Interventional Approaches for ALI/ARDS: Cell-Based Gene Therapy
by: Ying-Gang Zhu, et al.
Published: (2011-01-01)